JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4951
Norwood Financial Corp
NWFL
$368M
| $53K | ﹤0.01% |
1,586
+183
| +13% | +$5.94K |
2017 Q4
6 quarters
|
|
|
AY
4952
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $53K | ﹤0.01% |
2,342
-40,670
| -95% | -$861K |
2015 Q3
15 quarters
|
|
4953
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $52K | ﹤0.01% |
3,832
+952
| +33% | +$14.8K |
2018 Q3
3 quarters
|
|
|
CAPD
4954
DELISTED
iPath Shiller CAPE ETN
CAPD
| $52K | ﹤0.01% |
3,870
| – | – |
2019 Q1
1 quarter
|
|
|
HBMD
4955
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $52K | ﹤0.01% |
3,539
+350
| +11% | +$4.97K |
2017 Q2
8 quarters
|
|
|
IHC
4956
DELISTED
Independence Holding Company
IHC
| $52K | ﹤0.01% |
1,364
+54
| +4% | +$2K |
2017 Q4
6 quarters
|
|
|
SPN
4957
DELISTED
Superior Energy Services, Inc.
SPN
| $52K | ﹤0.01% |
4,268
-41,744
| -91% | -$1.23M |
2013 Q2
24 quarters
|
|
4958
American Superconductor
AMSC
$1.45B
| $51K | ﹤0.01% |
5,769
+5,283
| +1,087% | +$56.2K |
2015 Q4
14 quarters
|
|
4959
Amplify Blockchain Technology ETF
BLOK
$1.12B
| $51K | ﹤0.01% |
2,808
-1,000
| -26% | -$17.8K |
2018 Q1
5 quarters
|
|
|
LAND
4960
Gladstone Land Corp
LAND
$415M
| $51K | ﹤0.01% |
4,481
+967
| +28% | +$12K |
2016 Q2
12 quarters
|
|
4961
NetSol Technologies
NTWK
$73.7M
| $51K | ﹤0.01% |
9,058
+1,424
| +19% | +$9.18K |
2018 Q4
2 quarters
|
|
4962
VanEck Pharmaceutical ETF
PPH
$1.02B
| $51K | ﹤0.01% |
880
| – | – |
2015 Q1
17 quarters
|
|
4963
Stagwell
STGW
$2.1B
| $51K | ﹤0.01% |
20,413
-227,969
| -92% | -$587K |
2016 Q2
12 quarters
|
|
|
IIN
4964
DELISTED
IntriCon Corporation
IIN
| $51K | ﹤0.01% |
2,254
-13,799
| -86% | -$345K |
2018 Q1
5 quarters
|
|
|
SLCT
4965
DELISTED
Select Bancorp, Inc.
SLCT
| $51K | ﹤0.01% |
4,503
+724
| +19% | +$8.38K |
2018 Q2
4 quarters
|
|
4966
BGSF Inc
BGSF
$53.8M
| $50K | ﹤0.01% |
2,727
+610
| +29% | +$12.4K |
2016 Q4
10 quarters
|
|
4967
Fidelity D&D Bancorp
FDBC
$321M
| $50K | ﹤0.01% |
767
+85
| +12% | +$5.13K |
2018 Q2
4 quarters
|
|
4968
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.13B
| $50K | ﹤0.01% |
1,200
| – | – |
2015 Q4
14 quarters
|
|
4969
International Money Express
IMXI
$356M
| $50K | ﹤0.01% |
3,557
-14,924
| -81% | -$191K |
2019 Q1
1 quarter
|
|
4970
Rocky Brands
RCKY
$344M
| $50K | ﹤0.01% |
1,905
+238
| +14% | +$6.06K |
2016 Q2
12 quarters
|
|
4971
Syndax Pharmaceuticals
SNDX
$1.59B
| $50K | ﹤0.01% |
5,522
+1,902
| +53% | +$13.9K |
2016 Q4
10 quarters
|
|
4972
Transmedics
TMDX
$2.87B
| $50K | ﹤0.01% |
+1,813
| New | +$49.5K |
2019 Q2
0 quarters
|
|
|
GPX
4973
DELISTED
GP Strategies Corp.
GPX
| $50K | ﹤0.01% |
3,476
+450
| +15% | +$6.2K |
2017 Q4
6 quarters
|
|
|
CBMG
4974
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $50K | ﹤0.01% |
3,329
+498
| +18% | +$8.13K |
2018 Q2
4 quarters
|
|
|
CCRD
4975
DELISTED
CoreCard
CCRD
| $49K | ﹤0.01% |
+1,873
| New | +$62.3K |
2019 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.